The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis (Q33838726)

29 July 2017

1 reference

title

The role of angiotensin II and plasminogen activator inhibitor-1 in progressive glomerulosclerosis (English)

1 reference

29 July 2017

1 reference

1 reference

Fogo AB

1 reference

29 July 2017

publication date

1 February 2000

1 reference

American Journal of Kidney Diseases

29 July 2017

published in

1 reference

29 July 2017

1 reference

29 July 2017

1 reference

29 July 2017

page(s)

179-188

1 reference

The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy. The Collaborative Study Group

29 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Long-term benefits of angiotensin-converting enzyme inhibitor therapy in patients with severe immunoglobulin a nephropathy: a comparison to patients receiving treatment with other antihypertensive agents and to patients receiving no therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency. The Angiotensin-Converting-Enzyme Inhibition in Progressive Renal Insufficiency Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Effect of antihypertensive therapy on the kidney in patients with diabetes: a meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Modulation of plasminogen activator inhibitor-1 in vivo: a new mechanism for the anti-fibrotic effect of renin-angiotensin inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Angiotensin II receptor antagonists in the prevention of radiation nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Control of glomerular hypertension limits glomerular injury in rats with reduced renal mass

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Serial micropuncture analysis of glomerular function in two rat models of glomerular sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Therapeutic advantage of converting enzyme inhibitors in arresting progressive renal disease associated with systemic hypertension in the rat

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Dietary protein intake and the progressive nature of kidney disease: the role of hemodynamically mediated glomerular injury in the pathogenesis of progressive glomerular sclerosis in aging, renal ablation, and intrinsic renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Serial micropuncture analysis of single nephron function in subtotal renal ablation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Glomerular hemodynamic changes vs. hypertrophy in experimental glomerular sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Effects of antihypertensive drugs on glomerular morphology

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Glomerular hypertrophy in minimal change disease predicts subsequent progression to focal glomerular sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Glomerular volume and renal function in children with different types of the nephrotic syndrome.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Glomerular growth in childhood focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

A quantitative analysis of the glomeruli in focal segmental glomerulosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Angiotensin II type 2 receptor mediates programmed cell death

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Effects on blood pressure and exploratory behaviour of mice lacking angiotensin II type-2 receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Accelerated fibrosis and collagen deposition develop in the renal interstitium of angiotensin type 2 receptor null mutant mice during ureteral obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Angiotensin type 2 receptors are reexpressed by cardiac fibroblasts from failing myopathic hamster hearts and inhibit cell growth and fibrillar collagen metabolism

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Autoradiographic identification of kidney angiotensin IV binding sites and angiotensin IV-induced renal cortical blood flow changes in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Cause of variable therapeutic efficiency of angiotensin converting enzyme inhibitor on glomerular lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Enalapril and low protein reverse chronic puromycin aminonucleoside nephropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Transforming growth factor-beta and angiotensin II: the missing link from glomerular hyperfiltration to glomerulosclerosis?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

The Renin-Angiotensin and fibrinolytic systems co-conspirators in the pathogenesis of ischemic cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

The plasminogen activator/plasmin system

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Analysis of the plasminogen system on rat glomerular epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Bleeding diathesis due to decreased functional activity of type 1 plasminogen activator inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Brief report: complete deficiency of plasminogen-activator inhibitor type 1 due to a frame-shift mutation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Development of venous occlusions in mice transgenic for the plasminogen activator inhibitor-1 gene

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Angiotensin induction of PAI-1 expression in endothelial cells is mediated by the hexapeptide angiotensin IV

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Angiotensin II regulates the expression of plasminogen activator inhibitor-1 in cultured endothelial cells. A potential link between the renin-angiotensin system and thrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Angiotensin II induces plasminogen activator inhibitor-1 and -2 expression in vascular endothelial and smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Angiotensin II increases plasminogen activator inhibitor type 1 and tissue-type plasminogen activator messenger RNA in cultured rat aortic smooth muscle cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Dual effects of angiotensin II on the plasminogen/plasmin system in rat mesangial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Angiotensin-converting enzyme inhibition suppresses plasminogen activator inhibitor-1 expression in the neointima of balloon-injured rat aorta

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Plasminogen and plasminogen activators protect against renal injury in crescentic glomerulonephritis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Plasminogen activator inhibitor activity in diarrhoea-associated haemolytic uraemic syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Different expression of the plasminogen activation system in renal thrombotic microangiopathy and the normal human kidney

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

The renin-angiotensin system and fibrinolysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Stimulation of plasminogen activator inhibitor in vivo by infusion of angiotensin II. Evidence of a potential interaction between the renin-angiotensin system and fibrinolytic function

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Effects of ramipril on plasma fibrinolytic balance in patients with acute anterior myocardial infarction. HEART Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

A meta-analysis of the association of the deletion allele of the angiotensin-converting enzyme gene with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Allele-specific increase in basal transcription of the plasminogen-activator inhibitor 1 gene is associated with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Polymorphisms of angiotensin converting enzyme and plasminogen activator inhibitor-1 genes in diabetes and macroangiopathy1

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Pathophysiology of hypertensive renal damage.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

A new model of renal microvascular injury

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Endothelial function as a determinant of vascular function and structure: a new therapeutic target

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

Renal protective effect of angiotensin-converting enzyme inhibition in aging rats

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2800%2970324-6

7 January 2021

10.1016/S0272-6386(00)70324-6

Identifiers

DOI

1 reference

29 July 2017

1 reference